Items where the Publication is BMC musculoskeletal disorders

Number of items: 10.
2021
  • Association between circulating 25-hydroxyvitamin D concentrations and hip replacement for osteoarthritis: a prospective cohort study. (2021) Hussain, Sultana Monira; Wang, Yuanyuan; Heath, Alicia K; Giles, Graham G; English, Dallas R; Eyles, Darryl W; Williamson, Elizabeth J; Graves, Stephen E; Wluka, Anita E; Cicuttini, Flavia M
  • Childhood musculoskeletal impairment in Malawi from traumatic and non-traumatic causes: a population- based assessment using the key informant method. (2021) Linder, Cortland L; Atijosan-Ayodele, Oluwarantimi; Chokotho, Linda; Mulwafu, Wakisa; Tataryn, Myroslava; Polack, Sarah; Kuper, Hannah; Pandit, Hemant; Lavy, Chris
  • 2018
  • A comparison of outcome measures used to report clubfoot treatment with the Ponseti method: results from a cohort in Harare, Zimbabwe. (2018) Smythe, Tracey; Gova, Maxman; Muzarurwi, Rumbidzai; Foster, Allen; Lavy, Christopher
  • 2017
  • Association between the ossific nucleus and osteonecrosis in treating developmental dysplasia of the Hip: updated meta-analysis. (2017) Niziol, Rafal; Elvey, Michael; Protopapa, Evangelia; Roposch, Andreas
  • Assessment of success of the Ponseti method of clubfoot management in sub-Saharan Africa: a systematic review. (2017) Smythe, Tracey; Mudariki, Debra; Kuper, Hannah; Lavy, Christopher; Foster, Allen
  • 2016
  • Pain coping skills training for African Americans with osteoarthritis (STAART): study protocol of a randomized controlled trial. (2016) Schrubbe, Leah A; Ravyts, Scott G; Benas, Bernadette C; Campbell, Lisa C; CenĂ©, Crystal W; Coffman, Cynthia J; Gunn, Alexander H; Keefe, Francis J; Nagle, Caroline T; Oddone, Eugene Z; Somers, Tamara J; Stanwyck, Catherine L; Taylor, Shannon S; Allen, Kelli D
  • The most relevant diagnostic criteria for developmental dysplasia of the hip: a study of British specialists. (2016) Williams, Daniel; Protopapa, Evangelia; Stohr, Kuldeep; Hunter, James B; Roposch, Andreas
  • 2014
  • The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug. (2014) Navarro Coy, Nuria C; Brown, Sarah; Bosworth, Ailsa; Davies, Claire T; Emery, Paul; Everett, Colin C; Fernandez, Catherine; Gray, Janine C; Hartley, Suzanne; Hulme, Claire; Keenan, Anne-Maree; McCabe, Christopher; Redmond, Anthony; Reynolds, Catherine; Scott, David; Sharples, Linda D; Pavitt, Sue; Buch, Maya H
  • 2013
  • Efficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis. (2013) He, Ying; Wong, Angel YS; Chan, Esther W; Lau, Wallis CY; Man, Kenneth KC; Chui, Celine SL; Worsley, Alan J; Wong, Ian CK
  • 2007
  • Musculoskeletal impairment survey in Rwanda: design of survey tool, survey methodology, and results of the pilot study (a cross sectional survey). (2007) Atijosan, Oluwarantimi; Kuper, Hannah; Rischewski, Dorothea; Simms, Victoria; Lavy, Christopher picture_as_pdf